Ascent Group, LLC Merck & Co., Inc. Transaction History

Ascent Group, LLC

$1.29 Billion
Q3 2024

A detailed history of Ascent Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ascent Group, LLC holds 45,931 shares of MRK stock, worth $4.5 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

45,931

Previous 47,752 3.81%

Holding current value

$4.5 Million

Previous $5.91 Million 11.77%

% of portfolio

0.4%

Previous 0.49%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $202,404 - $234,854	-1,821 Reduced 3.81%	45,931 $5.22 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $454,346 - $487,963	-3,670 Reduced 7.14%	47,752 $5.91 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $1.7 Million - $1.98 Million	14,974 Added 41.08%	51,422 $6.79 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $41,574 - $45,243	415 Added 1.15%	36,448 $3.97 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $295,466 - $328,127	2,870 Added 8.65%	36,033 $3.71 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $1.11 Million - $1.21 Million	-10,182 Reduced 23.49%	33,163 $3.83 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $903,813 - $1.01 Million	-8,780 Reduced 16.84%	43,345 $4.61 Million
Q4 2022 Feb 16, 2023	BUY	$87.44 - $112.11 $86,478 - $110,876	989 Added 1.93%	52,125 $5.78 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $517,577 - $581,440	6,123 Added 13.6%	51,136 $5.18 Million
Q2 2022 Aug 05, 2022	BUY	$83.49 - $94.64 $515,717 - $584,591	6,177 Added 15.91%	45,013 $4.02 Million
Q1 2022 May 10, 2022	BUY	$73.51 - $82.4 $105,339 - $118,079	1,433 Added 3.83%	38,836 $3.19 Million
Q4 2021 Mar 01, 2022	BUY	$72.28 - $90.54 $2.7 Million - $3.39 Million	37,403 New	37,403 $2.99 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.

Account